Mary Pao

Mary Pao currently serves as the Chief Medical Officer at ANI Pharmaceuticals, Inc. since May 2021. Previously, Mary Pao held the position of Head of Clinical Affairs at W2O Group from October 2019 to May 2021, and worked as the Medical Lead and Partner at Arcus Medica from March 2012 to October 2019, focusing on medical communications in various therapeutic areas. Prior experience includes roles as Global Medical Affairs Lead at GlaxoSmithKline, Medical Director at Cephalon, and Assistant Medical Director at Genentech, along with a fellowship in Pediatric Hematology-Oncology at Memorial Sloan-Kettering Cancer Center. Education includes a PhD in Immunology and MD from New York University, an internship and residency in Medicine from Harvard Medical School, and a BA in Molecular Biology from Princeton University.